However, the gastrointestinal side effects commonly associated with GLP-1 RAs, such as nausea, vomiting, diarrhea, bloating, constipation, pancreatitis, gastroparesis, and bowel obstruction, may affect long-term patient compliance and limit their widespread clinical use [84]
Weight loss happens for many reasons: diet changes, exercise, placebo effect, or using other treatments at the same time
Studies have also shown that Linagliptin is safe for use in patients with renal and hepatic impairments, elderly patients, and those with cardiovascular risk factors, broadening its applicability across diverse patient populations
Site selection, rotation rules, and technique are the same
On the surface, it looked transformative
h - p , Glucose-stimulated insulin secretion